Randomized, comparative study of interferon β-1a treatment regimens in MS
Hillel Panitch(University of Vermont), Brian G. Weinshenker(Mayo Clinic in Arizona), Douglas S. Goodin(San Francisco VA Medical Center), Monaghan Ed(St. Michael's Hospital), Paul O’Connor(Feinstein Institute for Medical Research), D. Li(St. Michael's Hospital), Peter Chang(St. Michael's Hospital), G. Francis(St. Michael's Hospital), Patricia K. Coyle(St. Michael's Hospital)
Cited by 633
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k